Notice To Announce Request for Information (RFI) Inviting Input on NIAAA's 2022-2026 Strategic Plan Outline, 33324-33325 [2021-13239]
Download as PDF
<![CDATA[
33324
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 17, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13279 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK U24 SEP.
Date: July 9, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Xiaodu Guo, M.D., Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 14, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13340 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trials of Pharmacologic or Devicebased Interventions for Mental Disorders
(R61, R33, U01).
Date: July 14, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Mental Health, 6001 Executive Blvd.,
Neuroscience Center, Room 6150, Bethesda,
MD 20892, 301–435–1260, jasenka.borzan@
nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Social Drivers of Mental Illnesses in Low- &
Middle-Income Countries: Mechanisms and
Pathways of Interventions for Youth (R01).
Date: July 15, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
Dated: June 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13338 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice To Announce Request for
Information (RFI) Inviting Input on
NIAAA’s 2022–2026 Strategic Plan
Outline
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institute on
Alcohol Abuse and Alcoholism
(NIAAA) is currently developing an
updated strategic plan to highlight
priorities and guide activities for
advancing the Institute’s mission over
the next five years. Through this
Request for Information, NIAAA seeks
comments on the draft outline for its FY
2022–2026 Strategic Plan from diverse
stakeholders, including scientific
experts, health care providers, patients
and family members, advocacy groups,
other federal agencies, and nongovernmental scientific, professional,
and healthcare organizations.
DATES: Comments must be received by
July 30, 2021, to ensure consideration.
Responses will be reviewed by NIAAA
staff and considered during the
development of the 2022–2026 Strategic
Plan.
ADDRESSES: To view and comment on
the strategic plan outline, please visit
our online response form: RFI online
response form.
FOR FURTHER INFORMATION CONTACT:
Rachel I. Anderson, Strategic Plan
Coordinator, Office of Science Policy
and Communications, National Institute
on Alcohol Abuse and Alcoholism, NIH,
6700B Rockledge Drive, Bethesda, MD
20817. Telephone: 301–827–4681.
Email: NIAAASciencePolicyBranch@
nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with the 21st Century Cures
Act, NIH institutes are required to
regularly update their strategic plans.
The mission of the National Institute on
Alcohol Abuse and Alcoholism
(NIAAA) is to generate and disseminate
fundamental knowledge about the
effects of alcohol on health and wellbeing, and apply that knowledge to
improve diagnosis, prevention, and
treatment of alcohol-related problems,
SUMMARY:
E:\FR\FM\24JNN1.SGM
24JNN1
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
including alcohol use disorder, across
the lifespan. NIAAA is the world’s
largest funder of alcohol research.
National Institutes of Health
Dated: June 16, 2021.
Vicki E. Buckley,
Associate Director of Administration,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health.
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
[FR Doc. 2021–13239 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; New Technologies for the In
Vivo Delivery of Gene Therapeutics for an
HIV Cure (R01 Clinical Trial Not Allowed).
Date: July 16, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22B,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Kristina S. Wickham,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22B,
Rockville, MD 20852, 301–761–5390,
kristina.wickham@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 17, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13219 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials in Neurology.
Date: July 12–13, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Rockville, MD 20852,
(301) 435–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; P01 Review.
Date: July 19–23, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Li Jia, Ph.D., Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Research, NINDS/
NIH, 6001 Executive Boulevard, Room
3208D, Rockville, MD 20852, 301 451–2854,
li.jia@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Initial Translation Efforts for
Non-Addictive Analgesic Therapeutics
Development.
Date: July 21–22, 2021.
Time: 9:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
33325
Contact Person: Diana M. Cummings,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of
Neurological Disorders and Stroke, NIH,
NSC, 6001 Executive Blvd., Suite 3208,
Rockville, MD 20852, cummingsdi@
ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: June 15, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13347 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group Developmental Biology Study
Section.
Date: June 25, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
2121D, Bethesda, MD 20817, (Virtual
Meeting).
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
Room 2121D, Bethesda, MD 20892–7510,
(301) 435–6878, cathy.wedeen@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 86, Number 119 (Thursday, June 24, 2021)]
[Notices]
[Pages 33324-33325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13239]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice To Announce Request for Information (RFI) Inviting Input
on NIAAA's 2022-2026 Strategic Plan Outline
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute on Alcohol Abuse and Alcoholism (NIAAA)
is currently developing an updated strategic plan to highlight
priorities and guide activities for advancing the Institute's mission
over the next five years. Through this Request for Information, NIAAA
seeks comments on the draft outline for its FY 2022-2026 Strategic Plan
from diverse stakeholders, including scientific experts, health care
providers, patients and family members, advocacy groups, other federal
agencies, and non-governmental scientific, professional, and healthcare
organizations.
DATES: Comments must be received by July 30, 2021, to ensure
consideration. Responses will be reviewed by NIAAA staff and considered
during the development of the 2022-2026 Strategic Plan.
ADDRESSES: To view and comment on the strategic plan outline, please
visit our online response form: RFI online response form.
FOR FURTHER INFORMATION CONTACT: Rachel I. Anderson, Strategic Plan
Coordinator, Office of Science Policy and Communications, National
Institute on Alcohol Abuse and Alcoholism, NIH, 6700B Rockledge Drive,
Bethesda, MD 20817. Telephone: 301-827-4681. Email:
[email protected].
SUPPLEMENTARY INFORMATION: In accordance with the 21st Century Cures
Act, NIH institutes are required to regularly update their strategic
plans. The mission of the National Institute on Alcohol Abuse and
Alcoholism (NIAAA) is to generate and disseminate fundamental knowledge
about the effects of alcohol on health and well-being, and apply that
knowledge to improve diagnosis, prevention, and treatment of alcohol-
related problems,
[[Page 33325]]
including alcohol use disorder, across the lifespan. NIAAA is the
world's largest funder of alcohol research.
Dated: June 16, 2021.
Vicki E. Buckley,
Associate Director of Administration, National Institute on Alcohol
Abuse and Alcoholism, National Institutes of Health.
[FR Doc. 2021-13239 Filed 6-23-21; 8:45 am]
BILLING CODE 4140-01-P
